Correction to: OnabotulinumtoxinA in Chronic Migraine: A Profile of Its Use

被引：0
|
作者：
James E. Frampton
机构：
[1] Springer Nature,
来源：
CNS Drugs | 2021年 / 35卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
A correction to this paper has been published: https://doi.org/10.1007/s40263-021-00828-7
引用
收藏
页码：701 / 701
相关论文
共 50 条
  • [41] Effect of OnabotulinumtoxinA Injection on Depression in Chronic Migraine
    Maasumi, Kasra
    Thompson, Nicolas R.
    Kriegler, Jennifer S.
    Tepper, Stewart J.
    HEADACHE, 2015, 55 (09): : 1218 - 1224
  • [42] Correction to: Fostamatinib in chronic immune thrombocytopenia: a profile of its use in the USA
    Kate McKeage
    Katherine A. Lyseng-Williamson
    Drugs & Therapy Perspectives, 2018, 34 (12) : 594 - 594
  • [43] Fremanezumab in the prevention of migraine: a profile of its use
    Yvette N. Lamb
    Drugs & Therapy Perspectives, 2019, 35 : 592 - 600
  • [44] Erenumab in the prophylaxis of migraine: a profile of its use
    Emma H. McCafferty
    Katherine A. Lyseng-Williamson
    Drugs & Therapy Perspectives, 2019, 35 : 13 - 20
  • [45] Fremanezumab in the prevention of migraine: a profile of its use
    Lamb, Yvette N.
    DRUGS & THERAPY PERSPECTIVES, 2019, 35 (12) : 592 - 600
  • [46] Erenumab in the prophylaxis of migraine: a profile of its use
    McCafferty, Emma H.
    Lyseng-Williamson, Katherine A.
    DRUGS & THERAPY PERSPECTIVES, 2019, 35 (01) : 13 - 20
  • [47] Real-life use of onabotulinumtoxinA for the symptomatic treatment of chronic migraine: The Repose Study
    Ahmed, Fayyaz
    Gaul, Charly
    Martelletti, Paolo
    Carlos Garcia-Monco, Juan
    Adams, Aubrey Manack
    JOURNAL OF HEADACHE AND PAIN, 2017, 18
  • [48] Efficacy of Fremanezumab in Patients with Chronic Migraine Who Had Prior Use of Topiramate or OnabotulinumtoxinA
    Spierings, E. L. H.
    Yeung, P. P.
    Blankenbiller, T.
    Ning, X.
    Yang, R.
    Ma, Y.
    Bigal, M.
    Aycardi, E.
    HEADACHE, 2018, 58 : 83 - 83
  • [49] Real-Life Use of OnabotulinumtoxinA for the Symptomatic Treatment of Chronic Migraine: The Repose Study
    Ahmed, Fayyaz
    Gaul, Charly
    Martelletti, Paolo
    Garcia-Monco, Juan Carlos
    Adams, Aubrey Manack
    CEPHALALGIA, 2017, 37 : 94 - 94
  • [50] Evaluation of the concomitant use of oral preventive treatments and onabotulinumtoxinA in chronic migraine: the PREVENBOX study
    Alpuente, A.
    Gallardo, V. J.
    Torres-Ferrus, M.
    Santos-Lasaosa, S.
    Guerrero, A. L.
    Lainez, J. M.
    Viguera, J.
    Gago-Veiga, A.
    Irimia, P.
    del Rio, M. Sanchez
    Pozo-Rosich, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 (10) : 2102 - 2108
12345